VYGR
Voyager Therapeutics·NASDAQ
--
--(--)
--
--(--)
VYGR fundamentals
Voyager Therapeutics (VYGR) released its earnings on Nov 10, 2025: revenue was 13.37M (YoY -45.73%), beat estimates; EPS was -0.47 (YoY -193.75%), beat estimates.
Revenue / YoY
13.37M
-45.73%
EPS / YoY
-0.47
-193.75%
Report date
Nov 10, 2025
Earnings
EPS
Revenue
Revenue & Expenses
VYGR has released its 2025 Q4 earnings report, with revenue of 15.34M, reflecting a YoY change of 144.28%, and net profit of -27.43M, showing a YoY change of 20.47%. The Sankey diagram below clearly presents VYGR's revenue sources and cost distribution.
Key Indicators
Voyager Therapeutics (VYGR) key financial stats and ratios, covering profitability, financial health, and leverage.
Income Statement
Voyager Therapeutics (VYGR)'s revenue and profit trends over recent years, visualized with a waterfall chart to showcase the revenue-to-profit funnel.
Trend
Breakdown
Balance Sheet
Voyager Therapeutics (VYGR)'s asset and liability trends over recent years, visualized with a waterfall chart to illustrate changes in its asset-liability structure.
Trend
Breakdown
Cash Flow
Voyager Therapeutics (VYGR)'s cash flow trends over recent years, visualized with a waterfall chart to illustrate changes in its operating, investing, and financing cash flows.
Trend
Breakdown
Revenue Breakdown
Where does Voyager Therapeutics (VYGR) generate its revenue? Explore its key revenue streams and top earning regions.
By Business
Data source:
By Region
Data source:
Dividend
Track Voyager Therapeutics (VYGR) Dividend Yield, Payout Ratio & Sustainability Through Its Dividend History
Payout Ratio
Dividend Yield
You can ask Aime
What guidance did Voyager Therapeutics's management provide for the next earnings period?What is Voyager Therapeutics's latest dividend and current dividend yield?What does Voyager Therapeutics do and what are its main business segments?What factors drove the changes in Voyager Therapeutics's revenue and profit?What were the key takeaways from Voyager Therapeutics’s earnings call?Did Voyager Therapeutics beat or miss consensus estimates last quarter?What is the revenue and EPS growth rate for Voyager Therapeutics year over year?What were the key takeaways from Voyager Therapeutics's earnings call?
ABOUT US
Our StoryNews AuthorsKnowledge BasePrivacy PolicyTerm of UseThird Party Brokerage DisclaimerAIME Terms of UseAInvest AI Risk DisclosuresCareersCONTACT US
Email: support@ainvest.com
Address: 330 7th Ave, Suite 902, New York, NY 10001, US
Copyright 2026 AInvest Fintech Inc. All rights reserved.
